https://www.selleckchem.com/pr....oducts/Ubenimex(Best
In the current eighth edition head and neck TNM staging, extranodal extension (ENE) is an adverse feature in oral cavity squamous cell cancer (OSCC). The previous seventh edition N1 with ENE is now staged as N2a. Seventh edition N2+ with ENE is staged as N3b in the eighth edition. We evaluated its potential impact on patients treated with surgery and postoperative intensity-modulated radiotherapy (IMRT). OSCC patients treated with primary surgery and adjuvant (chemo)radiotherapy between January 2005 and December 2014 were rev
Like
Comment
Share
